Functional CD25bright+ alloresponsive T cells in fully immunosuppressed renal allograft recipients

被引:20
作者
Baan, Carla C.
Velthuis, Jurjen H. L.
van Gurp, Evelien A. F. J.
Mol, Wendy M.
Klepper, Mariska
Ijzermans, Jan N. M.
Weimar, Willem
机构
[1] Erasmus MC, Univ Med Ctr Rotterdam, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus MC, Univ Med Ctr Rotterdam, Dept Surg, NL-3000 DR Rotterdam, Netherlands
关键词
CD4+ CD25(bright+) regulatory T cells; kidney transplantation; patients;
D O I
10.1111/j.1399-0012.2006.00584.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Evidence from animal studies indicate a crucial role for CD25(bright+) regulatory T cells in transplantation tolerance. Methos: To assess whether peripheral CD25(bright+) T cells control immune responses in immunosuppressed kidney transplant patients, we analyzed the suppressive capacities of these cells using mixed lymphocytes reactions. Results: Allogeneic stimulation of patients peripheral blood mononuclear cells was associated with IL-2 production and T-cell proliferation. Depletion of CD25(bright+) T cells resulted in a 35% (median) higher IL-2 production and a 38% higher proliferative response against third party cells, showing that functional regulatory CD25(bright+) T cells were present (p = 0.03 and 0.02 respectively). In eight out of 11 patients, we also demonstrated regulation activity against donor-activated T cells (p = 0.03). These data were confirmed in coculture experiments with isolated CD25(-/dim) T cells plus CD25(bright+) T cells. At a 1:2 ratio, the CD25(bright+) T cells suppressed the proliferation of CD25(-/dim) donor- and third party-stimulated responder T cells. Conclusions: CD25(bright+) T cells with immune regulatory activities against anti-donor-responsive T cells are readily detectable in renal allograft recipients during treatment with full dosage immunosuppression. Whether CD25(bright+) T cells indeed play a role in graft acceptance after organ transplantation in patients remains to be elucidated.
引用
收藏
页码:63 / 71
页数:9
相关论文
共 37 条
  • [1] BAAN CC, 1994, CLIN EXP IMMUNOL, V97, P293
  • [2] Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin in human on the induction of FOXP3 T cells
    Baan, CC
    van der Mast, BJ
    Klepper, M
    Mol, WM
    Peeters, AMA
    Korevaar, SS
    Balk, AHMM
    Weimar, W
    [J]. TRANSPLANTATION, 2005, 80 (01) : 110 - 117
  • [3] Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantation
    Baan, CC
    Knoop, CJ
    van Gelder, T
    Holweg, CTJ
    Niesters, HGM
    Smeets, TJM
    van der Ham, F
    Zondervan, PE
    Maat, LPWM
    Balk, AHMM
    Weimar, W
    [J]. TRANSPLANTATION, 1999, 67 (06) : 870 - 876
  • [4] CD4+CD25high regulatory cells in human peripheral blood
    Baecher-Allan, C
    Brown, JA
    Freeman, GJ
    Hafler, DA
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (03) : 1245 - 1253
  • [5] Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
    Battaglia, M
    Stabilini, A
    Roncarolo, MG
    [J]. BLOOD, 2005, 105 (12) : 4743 - 4748
  • [6] Regulatory T-cell therapy: is it ready for the clinic?
    Bluestone, JA
    [J]. NATURE REVIEWS IMMUNOLOGY, 2005, 5 (04) : 343 - 349
  • [7] Role of regulatory T cells in human diseases
    Chatila, TA
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (05) : 949 - 959
  • [8] Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells
    Coenen, JJA
    Koenen, HJPM
    van Rijssen, E
    Hilbrands, LB
    Joosten, I
    [J]. BLOOD, 2006, 107 (03) : 1018 - 1023
  • [9] Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling
    D'Cruz, LM
    Klein, L
    [J]. NATURE IMMUNOLOGY, 2005, 6 (11) : 1152 - 1159
  • [10] Intragraft interleukin 2 mRNA expression during acute cellular rejection and left ventricular total wall thickness after heart transplantation
    de Groot-Kruseman, HA
    Baan, CC
    Hagman, EM
    Mol, WM
    Niesters, HG
    Maat, AP
    Zondervan, PE
    Weimar, W
    Balk, AH
    [J]. HEART, 2002, 87 (04) : 363 - 367